Specifically, the PD-1 alternative splice variant (PD-1Δex3) derived from RA T cells produces sPD-1 and antagonizes the inhibitory efficacy of membrane PD-1 on T cells, which is specific to RA and unrelated to the activation state of T cells. Here, PDCD1 is linked to rheumatoid arthritis.